Clinical trial
Erythropoietin Therapy for Subarachnoid Hemorrhage
NCT00140010 · University of Cambridge, Other · Completed
Key facts
| NCT number | NCT00140010 |
|---|---|
| Title | Erythropoietin Therapy for Subarachnoid Hemorrhage |
| Official title | Effects of Systemic Erythropoietin Therapy on Cerebral Autoregulation and Incidence of Delayed Ischemic Deficits in Patients With Aneurysmal Subarachnoid Hemorrhage |
| Lead sponsor | University of Cambridge, Other |
| Collaborators | Hoffmann-La Roche Industry Roche Foundation of Anemia Research (RoFAR, Switzerland) |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Aneurysmal Subarachnoid Hemorrhage |
| Intervention type | Drug |
| Interventions | erythropoietin beta |
| Enrollment | 80 |
| Start date | Apr 1, 2005 |
| Primary completion | Mar 1, 2007 |
| Completion | Mar 1, 2007 |
| First posted | Aug 31, 2005 |
| Last update posted | May 20, 2009 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: